The influence of beta receptor blocking drugs on plasma catecholamine levels in patients with essential hypertension
Rahn, K.H.
Archives Internationales de Pharmacodynamie et de Therapie Suppl: 54-57
1980
ISSN/ISBN: 0003-9780 PMID: 6106458 Document Number: 155740
Document emailed within 1 workday
Related Documents
Planz, G.; Corr, H.; Gierlichs, H.W.; Hawlina, A.; Planz, R.; Stephany, W.; Rahn, K.H. 1975: Dopamine-beta-hydroxylase activity and catecholamine concentration in plasma as a parameter of sympathetic tonus: effect of the ergometric test on patients with normotension and essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1066-1068Bhatia, J.; Mahajan, P.; Sikka, M.; Kalra, O.P. 2001: Effect of various antihypertensive drugs on plasma fibrinogen levels in patients with essential hypertension Indian Journal of Medical Sciences 55(9): 491-494
Brecht, H.M.; Vlachoyannis, J.; Musil, H.A.; Ernst, W.; Weismüller, G.; Schoeppe, W. 1975: Changes in plasma catecholamine concentration and cyclic AMP secretion following beta-blockade in essential hypertension Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1035-1038
Walter, I.; Kusus, T.; Wagner, K.; Lydtin, H. 1973: Effect of a beta receptor blocker on cardiac output--studies in essential hypertension and hyperkinetic heart syndrome with reference to plasma adrenaline and noradrenaline levels Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1010-1013
Planz, G.; Haass, H.; Lamberts, B. 1982: Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol International Journal of Clinical Pharmacology Therapy and Toxicology 20(10): 469-473
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40
Alvan, G.; von Bahr, C.; Seidemann, P.; Sjöqvist, F. 1982: High plasma concentrations of beta-receptor blocking drugs and deficient debrisoquine hydroxylation Lancet 1(8267): 333
Mäurer, W.; Kuhn, H.; Breithardt, G.; Kübler, W. 1975: Adrenaline, noradrenaline, and adenosine 3',5'-monophosphate levels in plasma of healthy persons during ergometric work with and without beta-receptor blocking agents Recent Advances in Studies on Cardiac Structure and Metabolism 7: 369-374
Planz, G.; Planz, R.; Gierlichs, H.W.; Rahn, K.H. 1978: Effect of the beta-receptor blocker propranolol on the catecholamin level and dopamin-beta-hydroxylase in patients with essential hypertension Die Medizinische Welt 29(9): 366-367
Tampier, L.; Alpers, H.S.; Davis, V.E. 1977: Influence of catecholamine-derived alkaloids and beta-adrenergic blocking agents on stereospecific binding of 3H-naloxone Research Communications in Chemical Pathology and Pharmacology 17(4): 731-734
Marta, R.; Goette, N.; Lev, P.; Heller, P.; Kornblihtt, L.; Vassallú, P.; Glembotsky, A.; Pirola, C.; Molinas, F. 2004: Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia Haematologica 89(6): 657-663
Sonkodi, S.; Pap, A.; Varró, V. 1976: Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes Therapia Hungarica 24(2): 60-62
Lang, R. 1980: Balance of noradrenaline and sodium during chronic beta-receptor blockade in patients with essential hypertension Archives Internationales de Pharmacodynamie et de Therapie Suppl: 67-75
Lechi, C.; Gaino, S.; Zuliani, V.; Tommasoli, R.M.; Faccini, G.; Fasson, R.; Arcaro, G.; Lechi, A.; Minuz, P. 2003: Elevated plasma fibrinogen levels in patients with essential hypertension are related to vascular complications International Angiology: a Journal of the International Union of Angiology 22(1): 72-78
Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Lorimer, A.R.; Jones, J.V.; Clark, B.; Dunn, F.G.; Melville, D.; Lawrie, T.D. 1976: Indications for beta-adrenoceptor blocking drugs in hypertension Postgraduate Medical Journal 52(Suppl 4): 81-85
Schulte, K.L.; Meyer-Sabellek, W.; Thiede, H.M.; Röcker, L.; Gotzen, R. 1987: Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol International Journal of Clinical Pharmacology Therapy and Toxicology 25(10): 539-544
Szurska, G.; Kleinrok, Z. 1978: The influence of beta-blocking agents on the kinin system in rat plasma Journal of Pharmacy and Pharmacology 30(5): 323-324
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Flouvat, B.; Roux, A.; Delhotal, B.; Lemaigre, D.; Leroy, M.; Liot, F. 1982: The beta-blocking effect of diacetolol in humans and its relationship to plasma levels International Journal of Clinical Pharmacology Therapy and Toxicology 20(8): 358-361